Skip to main content

The Effect of AR Overexpression on Androgen Signaling in Prostate Cancer

  • Chapter
  • First Online:
Androgen-Responsive Genes in Prostate Cancer

Abstract

Androgen receptor (AR) signaling pathway is required for both development of normal prostate gland and prostate cancer (PC). Patient with advanced disease are usually treated with androgen deprivation therapy. However, this treatment is only palliative, since a castration-resistant PC (CRPC) usually arises within 2–3 years of treatment. The mechanism by which CRPC develops is yet to be fully understood. However, common alteration in CRPC is the overexpression of the AR. Several studies have addressed the molecular changes occurring in AR overexpressing PC cells. The overexpression of AR enhances the binding of the receptor to chromatin in the presence of low concentrations of androgens. Furthermore, under the same conditions, AR overexpression alters also the dynamics of chromatin binding of the receptor and the binding of basic components of the transcriptional machinery. These changes translate into global epigenetic changes, which deserve more attention. Many studies have found that AR activation in CRPC cell models stimulates a different transcriptional program, which may be influenced by cooperative functions of other transcription factors. Thus, not only a single target gene but also a network of genes could be responsible for the disease progression. In fact, functional studies have shown that androgen-regulated genes, which are over­expressed in CRPC, are also likely to be important in PC progression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Huggins C, Hodges CV (1941) Cancer Res 1:293–297

    Article  PubMed  Google Scholar 

  2. Bélanger B, Bélanger A, Labrie F et al (1989) J Steroid Biochem 32:695–698

    Article  PubMed  Google Scholar 

  3. Liu J, Albert J, Geller J (1986) Prostate 9:199–205

    Article  PubMed  CAS  Google Scholar 

  4. Titus MA, Schell MJ, Lih FB et al (2005) Clin Cancer Res 11:4653–4657

    Article  PubMed  CAS  Google Scholar 

  5. Mohler JL (2008) Adv Exp Med Biol 617:223–234

    Article  PubMed  Google Scholar 

  6. Stanbrough M, Bubley GJ, Ross K et al (2006) Cancer Res 66:2815–2825

    Article  PubMed  CAS  Google Scholar 

  7. Mostaghel EA, Page ST, Lin DW et al (2007) Cancer Res 67:5033–5041

    Article  PubMed  CAS  Google Scholar 

  8. Locke JA, Guns ES, Lubik AA et al (2008) Cancer Res 68:6407–6415

    Article  PubMed  CAS  Google Scholar 

  9. Locke JA, Guns ES, Lehman ML (2010) Prostate 70:239–251

    PubMed  CAS  Google Scholar 

  10. de Bono JS, Logothetis CJ, Molina A et al (2011) N Engl J Med 364:1995–2005

    Article  PubMed  Google Scholar 

  11. Scher HI, Fizazi K, Saad F, et al (2012) N Engl J Med 367:1187–1197

    Google Scholar 

  12. Waltering KK, Urbanucci A, Visakorpi T (2012) Mol Cell Endocrinol 360:38–43

    Article  PubMed  CAS  Google Scholar 

  13. Dehm SM, Schmidt LJ, Heemers HV et al (2008) Cancer Res 68:5469–5477

    Article  PubMed  CAS  Google Scholar 

  14. Hu R, Dunn TA, Wei S et al (2009) Cancer Res 69:16–22

    Article  PubMed  CAS  Google Scholar 

  15. Guo Z, Yang X, Sun F et al (2009) Cancer Res 69:2305–2313

    Article  PubMed  CAS  Google Scholar 

  16. Visakorpi T, Hyytinen E, Koivisto P et al (1995) Nat Genet 9:401–406

    Article  PubMed  CAS  Google Scholar 

  17. Palmberg C, Koivisto P, Kakkola L et al (2000) J Urol 164:1992–1995

    Article  PubMed  CAS  Google Scholar 

  18. Linja MJ, Savinainen KJ, Saramäki OR et al (2001) Cancer Res 61:3550–3555

    PubMed  CAS  Google Scholar 

  19. Edwards J, Krishna NS, Grigor KM et al (2003) Br J Cancer 89:552–556

    Article  PubMed  CAS  Google Scholar 

  20. Chen CD, Welsbie DS, Tran C et al (2004) Nat Med 10:33–39

    Article  PubMed  Google Scholar 

  21. Tamura K, Furihata M, Tsunoda T (2007) Cancer Res 67:5117–5125

    Article  PubMed  CAS  Google Scholar 

  22. Liu W, Laitinen S, Khan S et al (2009) Nat Med 15:559–565

    Article  PubMed  CAS  Google Scholar 

  23. Taylor BS, Schultz N, Hieronymus H et al (2010) Cancer Cell 18:11–22

    Article  PubMed  CAS  Google Scholar 

  24. Wang LG, Johnson EM, Kinoshita Y et al (2008) Cancer Res 68:2678–2688

    Article  PubMed  CAS  Google Scholar 

  25. Li Y, Wang L, Zhang M et al (2009) Cancer Res 69:3332–3338

    Article  PubMed  CAS  Google Scholar 

  26. Sharma A, Yeow WS, Ertel A et al (2010) J Clin Invest 120:4478–4492

    Article  PubMed  CAS  Google Scholar 

  27. Cai C, He HH, Chen S et al (2011) Cancer Cell 20:457–471

    Article  PubMed  CAS  Google Scholar 

  28. Horoszewicz JS, Leong SS, Chu TM (1980) Prog Clin Biol Res 37:115–132

    PubMed  CAS  Google Scholar 

  29. Korenchuk S, Lehr JE, MClean L et al (2001) In Vivo 15:163–168

    PubMed  CAS  Google Scholar 

  30. Saramäki OR, Harjula AE, Martikainen PM et al (2008) Clin Cancer Res 14:3395–3400

    Article  PubMed  Google Scholar 

  31. Tomlins SA, Rhodes DR, Perner S et al (2005) Science 310:644–648

    Article  PubMed  CAS  Google Scholar 

  32. Waltering KK, Helenius MA, Sahu B et al (2009) Cancer Res 69:8141–8149

    Article  PubMed  CAS  Google Scholar 

  33. Culig Z, Hoffmann J, Erdel M et al (1999) Br J Cancer 81:242–251

    Article  PubMed  CAS  Google Scholar 

  34. Urbanucci A, Sahu B, Seppälä J et al (2012) Oncogene 31:2153–2163

    Article  PubMed  CAS  Google Scholar 

  35. Chang C, Kokontis J, Liao S (1988) Science 240:324–326

    Article  PubMed  CAS  Google Scholar 

  36. Lubahn DB, Joseph DR, Sar M et al (1988) Mol Endocr 2:1265–1275

    Article  CAS  Google Scholar 

  37. Perissi V, Rosenfeld MG (2005) Nat Rev Mol Cell Biol 6:542–554

    Article  PubMed  CAS  Google Scholar 

  38. Kokontis J, Takakura K, Hay N et al (1994) Cancer Res 54:1566–1573

    PubMed  CAS  Google Scholar 

  39. Gregory CW, Johnson RT Jr, Mohler JL et al (2001) Cancer Res 61:2892–2988

    PubMed  CAS  Google Scholar 

  40. Wang Q, Li W, Zhang Y et al (2009) Cell 138:245–256

    Article  PubMed  CAS  Google Scholar 

  41. Gregory CW, Johnson RT Jr et al (2001) J Androl 22:537–548

    PubMed  CAS  Google Scholar 

  42. Massie CE, Lynch A, Ramos-Montoya A et al (2011) EMBO J 30:2719–2033

    Article  PubMed  CAS  Google Scholar 

  43. Prescott J, Jariwala U, Jia L et al (2007) Prostate 67:1371–1383

    Article  PubMed  CAS  Google Scholar 

  44. Zhao JC, Yu J, Runkle C et al (2012) Genome Res 22:322–331

    Article  PubMed  CAS  Google Scholar 

  45. Reyes JC, Barra J, Muchardt C et al (1998) EMBO J 17:6979–6991

    Article  PubMed  CAS  Google Scholar 

  46. Xu J, Qiu Y, DeMayo FJ et al (1998) Science 279:1922–1925

    Article  PubMed  CAS  Google Scholar 

  47. Gehin M, Mark M, Dennefeld C et al (2002) Mol Cell Biol 22:5923–5937

    Article  PubMed  CAS  Google Scholar 

  48. Cheung-Flynn J, Prapapanich V, Cox MB (2005) Mol Endocrinol 19:1654–1666

    Article  PubMed  CAS  Google Scholar 

  49. Yong W, Yang Z, Periyasamy S et al (2007) J Biol Chem 282:5026–5036

    Article  PubMed  CAS  Google Scholar 

  50. Linja MJ, Porkka KP, Kang Z et al (2004) Clin Cancer Res 10:1032–1040

    Article  PubMed  CAS  Google Scholar 

  51. Agoulnik IU, Vaid A, Nakka M et al (2006) Cancer Res 66:10594–10602

    Article  PubMed  CAS  Google Scholar 

  52. Li P, Yu X, Ge K et al (2002) Am J Pathol 161:1467–1474

    Article  PubMed  CAS  Google Scholar 

  53. Mestayer C, Blanchère M, Jaubert F et al (2003) Prostate 56:192–200

    Article  PubMed  CAS  Google Scholar 

  54. Culig Z, Comuzzi B, Steiner H et al (2004) J Steroid Biochem Mol Biol 92:265–271

    Article  PubMed  CAS  Google Scholar 

  55. Comuzzi B, Nemes C, Schmidt S et al (2004) J Pathol 204:159–166

    Article  PubMed  CAS  Google Scholar 

  56. Hu XD, Meng QH, Xu JY et al (2011) Biochem Biophys Res Commun 404:903–909

    Article  PubMed  CAS  Google Scholar 

  57. Ficazzola MA, Fraiman M, Gitlin J et al (2001) Carcinogenesis 22:1271–1279

    Article  PubMed  CAS  Google Scholar 

  58. Jalava SE, Urbanucci A, Latonen L et al. (2012) Oncogene. doi:10.1038/onc.2011.624

    Google Scholar 

  59. Urbanucci A, Waltering KK, Suikki HE et al (2008) BMC Cancer 8:219

    Article  PubMed  Google Scholar 

  60. Heemers HV, Regan KM, Schmidt LJ et al (2009) Mol Endocrinol 23:572–583

    Article  PubMed  CAS  Google Scholar 

  61. Shah S, Prasad S, Knudsen KE (2012) Cancer Res 72:1248–1259

    Article  PubMed  CAS  Google Scholar 

  62. Wang Q, Li W, Liu XS et al (2007) Mol Cell 27:380–392

    Article  PubMed  Google Scholar 

  63. Massie CE, Adryan B, Barbosa-Morais NL et al (2007) EMBO Rep 8:871–878

    Article  PubMed  CAS  Google Scholar 

  64. Yu J, Mani RS et al (2010) Cancer Cell 17:443–454

    Article  PubMed  CAS  Google Scholar 

  65. Sahu B, Laakso M, Ovaska K et al (2011) EMBO J 30:3962–3976

    Article  PubMed  CAS  Google Scholar 

  66. Takayama K, Tsutsumi S, Katayama S et al (2011) Oncogene 30:619–630

    Article  PubMed  CAS  Google Scholar 

  67. Pereira de Jésus-Tran K, Côté PL, Cantin L et al (2006) Protein Sci 15:987–999

    Article  PubMed  Google Scholar 

  68. Isaacs JT, D’Antonio JM, Chen S (2012) Prostate. doi:10.1002/pros.22504

    Google Scholar 

  69. Kang Z, Pirskanen A, Jänne OA et al (2002) J Biol Chem 277:48366–48371

    Article  PubMed  CAS  Google Scholar 

  70. Perissi V, Jepsen K, Glass CK et al (2010) Nat Rev Genet 11:109–123

    Article  PubMed  CAS  Google Scholar 

  71. Urbanucci A, Marttila S, Jänne OA et al (2012) Prostate 72:1223–1232

    Article  PubMed  CAS  Google Scholar 

  72. Welsbie DS, Xu J, Chen Y et al (2009) Cancer Res 69:958–966

    Article  PubMed  CAS  Google Scholar 

  73. Makkonen H, Kauhanen M, Jääskeläinen T et al (2011) Mol Cell Endocrinol 331:57–65

    Article  PubMed  CAS  Google Scholar 

  74. Lupien M, Eeckhoute J, Meyer CA et al (2008) Cell 132:958–970

    Article  PubMed  CAS  Google Scholar 

  75. Wang D, Garcia-Bassets I, Benner C et al (2011) Nature 474:390–394

    Article  PubMed  CAS  Google Scholar 

  76. Nakayama T, Watanabe M, Suzuki H et al (2000) Lab Invest 80:1789–1796

    Article  PubMed  CAS  Google Scholar 

  77. Rahman M, Miyamoto H, Chang C (2004) Clin Cancer Res 10:2208–2219

    Article  PubMed  CAS  Google Scholar 

  78. Chmelar R, Buchanan G, Need EF et al (2006) Int J Cancer 120:719–733

    Article  Google Scholar 

  79. Heemers HV, Tindall DJ (2007) Endocr Rev 28:778–808

    Article  PubMed  CAS  Google Scholar 

  80. Strahl B, Allis C (2000) Nature 403:41–45

    Article  PubMed  CAS  Google Scholar 

  81. Verdone L, Agricola E, Caserta M et al (2006) Brief Funct Genomic Proteomic 5:209–221

    Article  PubMed  CAS  Google Scholar 

  82. Ito T (2007) J Biochem (Tokyo) 141:609–614

    Article  CAS  Google Scholar 

  83. Andreu-Vieyra C, Lai J, Berman BP et al (2011) Mol Cell Biol 31:4648–4662

    Article  PubMed  CAS  Google Scholar 

  84. Hurtado A, Holmes KA, Ross-Innes CS et al (2011) Nat Genet 43:27–33

    Article  PubMed  CAS  Google Scholar 

  85. Chuu CP, Kokontis JM, Hiipakka RA et al (2011) J Biomed Sci 18:63

    Article  PubMed  CAS  Google Scholar 

  86. Langenhuijsen JF, Badhauser D, Schaaf B et al (2012) Urol Oncol doi:10.1016/j.urolonc

    Google Scholar 

  87. Mottet N, Van Damme J, Loulidi S et al (2012) BJU Int. doi:10.1111/j.1464-410X.2012.11120.x

    Google Scholar 

  88. Mulholland DJ, Tran LM, Li Y et al (2011) Cancer Cell 19:792–804

    Article  PubMed  CAS  Google Scholar 

  89. Carver BS, Chapinski C, Wongvipat J et al (2011) Cancer Cell 19:575–586

    Article  PubMed  CAS  Google Scholar 

  90. Delmore JE, Issa GC, Lemieux ME et al (2011) Cell 146:904–917

    Article  PubMed  CAS  Google Scholar 

  91. Klein KA, Reiter RE, Redula J et al (1997) Nat Med 3:402–408

    Article  PubMed  CAS  Google Scholar 

  92. Veldscholte J, Ris-Stalpers C, Kuiper GG et al (1990) Biochem Biophys Res Commun 173:534–540

    Article  PubMed  CAS  Google Scholar 

  93. Lee YG, Korenchuk S, Lehr J et al (2001) In Vivo 15:157–162

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tapio Visakorpi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Urbanucci, A., Waltering, K.K., Mills, I.G., Visakorpi, T. (2013). The Effect of AR Overexpression on Androgen Signaling in Prostate Cancer. In: Wang, Z. (eds) Androgen-Responsive Genes in Prostate Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6182-1_12

Download citation

Publish with us

Policies and ethics